TUNE LSE Week ended 24 Jul 2026

Weekly Investor Report

Focusrite plc · Consumer Cyclical · Leisure

Open interactive chart View report data
Latest close 240.0 GBP
1.3% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 14.5% above the Trend Line and sits at 85.7% of its 52-week range. The latest completed week returned 1.3%, after a 25.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 48/100.

Setup score 64 out of 100
Latest Close 240.0 GBP 24 Jul 2026
1W Return 1.3% latest completed week
4W Return 25.5% short-term follow-through
12W Return 21.5% quarterly tape
Trend Breadth 50.0% 26 of 52 weeks active
Volume Ratio 1.7x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 38.45% based on similar historical setup states.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.3% Latest completed week; four-week move 25.5%. Indicator stack 28/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 38.45% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 48/100 9 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 14.5% above the Trend Line and sits at 85.7% of its 52-week range. The latest completed week returned 1.3%, after a 25.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.7x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3312-week average 0.15

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.33Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 25.5% over four weeks, 21.5% over 12 weeks, and 54.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.3%
4W25.5%
12W21.5%
26W0.0%
52W54.9%
Active trend streak0 weeks
Active weeks in one year26
Trend breadth50.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.25Latest activity-pressure read.
Pressure change5835.2%Four-week change in activity pressure.
Leadership9.36Latest relative-leadership reading.
RS change195.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Aug 2025 Field coverage 42% Model confidence 27%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength66/100Blend of value, momentum, and quality. Underlying universe rank 35; rank 1 is best.
Value59/100Relative valuation strength. Underlying universe rank 42; rank 1 is best.
Quality61/100Profitability and accounting quality. Underlying universe rank 40; rank 1 is best.
Momentum61/100Medium-term price momentum. Underlying universe rank 40; rank 1 is best.
Growth61/100Revenue and earnings growth. Underlying universe rank 40; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
0/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.8%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
2.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment48/100

Weighted news tone is neutral across 9 relevant articles.

0 positive · 8 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-5.9%Distance below the 52-week high.
13-week volatility6.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2611 weeks finished lower.
Best week+20.8%Week of 17 Apr.
Worst week-15.5%Week of 20 Mar.
Latest week+1.3%Week of 24 Jul.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks1
Modest losses4
Sharp losses7
Recent vol6.1%13-week weekly-return volatility.
Base vol8.4%52-week weekly-return volatility.
Up/down split28/23Count of positive and negative weeks in the 52-week window.
Average skew7.0% / -5.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape58/100

Trend, activity pressure, participation, and risk combine to a 58/100 tape read.

 Indicator analysis26/100

Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 3/12.

Activity pressure 0.33; No reversal markers Next-Week ExpectancyNegative 38.45%

Next-week expectancy is negative with a 38.45% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors61/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 56; Small Cap Core rank 52 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment48/100

Weighted news tone is neutral across 9 relevant articles.

M&G (LSE:MNG) Stock Sees Modest Fair Value Lift As Analysts Fine Tune Targets Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 2026240.0 GBP1.3%209.7 GBP291.4 GBP1.259.361.6MOff
17 Jul 2026237.0 GBP3.0%209.5 GBP293.5 GBP1.039.933.5MOff
10 Jul 2026230.0 GBP6.6%208.9 GBP295.3 GBP0.698.11656.0KOff
3 Jul 2026215.8 GBP12.8%208.4 GBP296.4 GBP0.42-0.023.1MOff
26 Jun 2026191.2 GBP-3.7%208.7 GBP297.9 GBP-0.02-9.81483.6KOff
19 Jun 2026198.6 GBP3.8%209.7 GBP299.4 GBP-0.21-5.1487.7KOff
12 Jun 2026191.2 GBP8.0%209.9 GBP301.1 GBP-0.39-9.6360.7KOff
5 Jun 2026177.0 GBP-9.7%211.0 GBP303.0 GBP-0.55-15.8061.8KOff
29 May 2026196.0 GBP4.5%213.1 GBP305.0 GBP-0.57-7.53304.6KOff
22 May 2026187.5 GBP-2.3%213.7 GBP306.8 GBP-0.51-12.00183.5KOff
15 May 2026192.0 GBP-1.5%214.0 GBP308.9 GBP-0.65-7.64349.3KOff
8 May 2026195.0 GBP-1.3%213.8 GBP311.3 GBP-0.59-6.35577.8KOff
1 May 2026197.5 GBP11.3%213.5 GBP313.6 GBP-0.64-6.321.4MOff
24 Apr 2026177.5 GBP-11.2%213.7 GBP315.9 GBP-0.88-15.71357.7KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.